ライフサイエンスコーパス: 99mTc-tetrofosmin

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 min and may be explained by the lower EF for 99mTc tetrofosmin.

2 y administration of 125I-labeled albumin and 99mTc-tetrofosmin.

3 201Tl but with smaller defect magnitudes for 99mTc-tetrofosmin.

4 0.66 +/- 0.04) was significantly higher than 99mTc-tetrofosmin (0.55 +/- 0.05; p < 0.05).

5 63 and 0.39; 99mTc-sestamibi, 0.62 and 0.34; 99mTc-tetrofosmin, 0.68 and 0.32; and 99mTcN-NOET, 0.71

6 99mTc-tetrofosmin (10 mCi), 201TI (1 mCi) and microspher

7 In protocol 1, 99mTc-tetrofosmin, 201 TI and microspheres were injected

8 In both protocols, myocardial 99mTc-tetrofosmin and 201TI activities were quantified f

9 eft circumflex (LCx) defect count ratios for 99mTc-tetrofosmin and 201TI from images of myocardial sl

10 ble coronary stenosis detection rate between 99mTc-tetrofosmin and 201Tl but with smaller defect magn

11 ave been developed, such as 99mTc-sestamibi, 99mTc-tetrofosmin and 99mTc-furifosmin.

12 Tc-Q3, 99mTc-Q4, 99mTc-Q12, 99mTc-sestamibi, 99mTc-tetrofosmin and 99mTcN-NOET) and 201Tl in a canine

13 adiopharmaceuticals such as 99mTc-sestamibi, 99mTc-tetrofosmin and 99Tc-furifosmin (Tc-Q12) have been

14 ress is better resolved with 201Tl than with 99mTc-tetrofosmin and may be explained by the lower EF f

15 Two hours later, 370 MBq (10 mCi) of 99mTc-tetrofosmin and microspheres were injected and an

16 goal of this study was to determine whether 99mTc-tetrofosmin can assess regional flow heterogeneity

17 d by well counting postmortem, and 201Tl and 99mTc-tetrofosmin defect magnitudes were determined by q

18 These data suggest that administration of 99mTc-tetrofosmin during coronary occlusion accurately d

19 Mean 99mTc-tetrofosmin EF was 54.0+/-3.7%.

20 imental studies validate the clinical use of 99mTc-tetrofosmin for assessing persistent coronary arte

21 LAD/LCx 99mTc-tetrofosmin image defect count ratio was similar t

22 unt ratios were comparable between 201TI and 99mTc-tetrofosmin in 1 and 3 h occluded dogs, and signif

23 ere significantly greater for 201Tl than for 99mTc-tetrofosmin in both groups.

24 e the first-pass extraction fraction (EF) of 99mTc-tetrofosmin in canine myocardium and to compare 99

25 Cx flow ratios were similar during 201Tl and 99mTc-tetrofosmin injections (0.48 +/- 0.04 versus 0.49

26 One-day dipyridamole/rest 99mTc-tetrofosmin myocardial perfusion imaging is feasib

27 Exercise 99mTc-tetrofosmin myocardial scintigraphy is as accurate

28 99mTc-tetrofosmin myocardial SPECT during vasodilation w

29 re 0.37+/-0.04 for 201Tl and 0.67+/-0.05 for 99mTc-tetrofosmin (P<.01).

30 s 0.58+/-0.04, compared with 0.81+/-0.04 for 99mTc-tetrofosmin (P<.01).

31 ar relationship between 201TI (r = 0.96) and 99mTc-tetrofosmin (r 0.92) activities and microsphere fl

32 thallium-201 and exercise 99mTc-sestamibi or 99mTc-tetrofosmin SPECT perfusion images were analyzed f

33 thallium) single photon emission CT (SPECT), 99mTc-tetrofosmin (tetrofosmin) SPECT, and dobutamine ci

34 th profound systolic dysfunction, myocardial 99mTc-tetrofosmin uptake ( > 50%) reflective of viabilit

35 Thus, in both groups, 99mTc-tetrofosmin uptake underestimated the flow dispari

36 When given after reperfusion, 99mTc-tetrofosmin uptake was significantly reduced in re

37 ng coronary artery (LAD) stenoses, 201Tl and 99mTc-tetrofosmin were administered during adenosine inf

38 rofosmin in canine myocardium and to compare 99mTc-tetrofosmin with 201Tl uptake during adenosine-ind

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。